Meditope Biosciences is a privately-held biotechnology company headquartered in Pasadena, California. We are committed to using our revolutionary SnAP technology to develop a broad array of antibody-based cancer therapeutics, independently and with collaborators. Our investors include qualified individual investors with a breadth and depth of experience in business, finance, and patent law, as well as the life sciences industry.

Carving a New Space

Learn about how our SnAP technology creates a unique binding site within the Fab region that adds functionality to monoclonal antibodies.

» Learn More